(Q36678707)

English

Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group

scientific article published on June 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

author name string

de Wit R

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Stoter G

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Sleijfer DT

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Kaye SB

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

de Mulder PH

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ten Bokkel Huinink WW

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Spaander PJ

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

de Pauw M

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Sylvester R

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 June 1995

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

71

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1311-1314

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1995.254

0 references

VP-16–213 salvage therapy for refractory germinal neoplasms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033818

30 September 2017

Multiple-drug resistance in human cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033818

30 September 2017

Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033818

30 September 2017

Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033818

30 September 2017

Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033818

30 September 2017

Prognostic factors in metastatic germ cell tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033818

30 September 2017

Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033818

28 June 2018

Chemotherapy for poor risk germ cell tumours. An independent evaluation of the POMB/ACE regime.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033818

28 June 2018

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033818

28 June 2018

Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033818

28 June 2018

BOP/VIP - A new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033818

28 June 2018

The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033818

28 June 2018

Rationale for the use of alternating non-cross-resistant chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033818

5 September 2018

Multivariate analysis of prognostic variables in patients with metastatic testicular cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033818

5 September 2018

The genetic origin of drug resistance in neoplasms: implications for systemic therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033818

5 September 2018

Ifosfamide in testicular cancer: the Indiana University experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1995.254

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36678707&oldid=1516752115"